He gave a mixed picture of the outlook. No improvement was seen in ANZ, though the restructuring would help restore earnings, while steady growth is expected in Asia, helping to offset a rise in fixed costs as the company added capacity. For Europe, Middle East and Africa (EMEA), demand rose in the second half of 2014 and was expected to hold at those levels in coming months. In the Americas, Nuplex expects a continuation of modest growth.
In the latest year, ANZ Resins posted a 15 percent decline in sales and a 37 percent drop in operating earnings before interest, tax, depreciation and amortisation though that was more than made up for by earnings growth in Asia and Europe, Middle East and Africa. Total sales for Resins fell 0.2 percent to $1.35 billion in the latest year, while operating Ebitda climbed 11 percent to $111.5 million.
The company's Specialties division, which is made up of Nupplex Specialities and Nuplex Masterbatch, recorded a 7.1 percent decline in sales to $289.7 million, while operating Ebitda tumbled 44 percent to $14.2 million.
Capital spending was $42 million in 2014 as Nuplex invested in its Changshu and Suzhou sites in China, upgraded its Wacol site in Queenland, Australia, and invested in plant in Russia and Indonesia. For the 2015 year, capex is expected to fall to about $35 million.
Nuplex will pay a final dividend of 11 cents on Oct. 13, with a record date of Sept. 29, bringing payments for the year to 21 cents. Gearing rose to 31 percent as at June 30 from 26 percent a year earlier, reflecting investment in new capacity in Asia and an acquisition in Russia. The company tries to keep gearing within a range of 20 percent to 35 percent.
The shares last traded at $2.89 and have fallen 15 percent this year.